TransMedics Raises 2026 Revenue Outlook After 41% Q3 Growth; Adjusted EPS Dips
TransMedics' third-quarter revenue rose 41% to $203.0 million and the company raised its 2026 revenue forecast, but adjusted EPS of $0.51 trailed last year's $0.67. Shares closed Friday 27.92% above Thursday's close.

